ProMIS Neurosciences Inc PMN

cashman presented last week

[Gbathat]

I could not find slides but...

https://neurodegenerative-drug-development.com/about/day-one/


11:50 am Precision Immunotherapies for Protein Misfolding Diseases to Advance ALS & FTD Therapeutics

• Neil CashmanCSO of ProMIS Neurosciences, Professor, Neurology, University of British Columbia

 

Synopsis

• Exploring how the ProMIS Platform is being leveraged to develop protein misfolding-specific immunotherapies for neurodegeneration
• Case study: selective targeting of toxic forms of TDP-43 in ALS and FTD, while sparing normally folded functional TDP-43
• Dissecting the role of prion-like propagation of misfolded proteins in neurodegeneration

[Speyeder999]

Good find......I also noticed that Jos Luis Molinuevo presented at the same event. Is he still on Promis's Advisory Board? Hard to follow, seems like all these advisory boards are like revolving doors......